| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Hsu T.-H.; WEI-YU LIAO; Yang P.-C.; Wang C.-C.; Xiao J.-L.; Lee C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Lee C.-H.;Hsu T.-H.;Wei-Yu Liao;Yang P.-C.;Wang C.-C.;Xiao J.-L.; Lee C.-H.; Hsu T.-H.; WEI-YU LIAO; Yang P.-C.; Wang C.-C.; Xiao J.-L. |
| 臺北醫學大學 |
2015 |
Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
|
Davis, PJ;Glinsky, GV;Lin, HY;Leith, JT;Hercbergs, A;Tang, HY;Ashur-Fabian, O;Incerpi, S;Mousa, SA |
| 國立交通大學 |
2014-12-08T15:23:46Z |
Cancer cell labeling and tracking using fluorescent and magnetic nanodiamond
|
Lien, Zhi-Yi; Hsu, Tzu-Chia; Liu, Kuang-Kai; Liao, Wei-Siang; Hwang, Kuo-Chu; Chao, Jui-I. |
| 國立東華大學 |
2007-11 |
Cancer cell targeting and therapy by growth hormone-nano-diamond complex
|
Chang Chia-Ching ; Pei-Hsin Chen ; Hsuen-Liang Chu ; Yu-Ching Chang ; Jen-Yin Su ; Jui-I Chao ; Chia-Liang Cheng ; Yen-Peng Ho ; Ken-Wen Sun ; Jyh Shin Chen ; Yin-Chang Liu |
| 國立臺灣大學 |
2008 |
Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods
|
Huang, Yu-Fen; Chang, Huan-Tsung; Tan, Weihong |
| 臺大學術典藏 |
2008 |
Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods
|
Huang, Yu-Fen; Chang, Huan-Tsung; Tan, Weihong; Huang, Yu-Fen; Chang, Huan-Tsung; Tan, Weihong |
| 臺大學術典藏 |
2020-06-11T06:12:05Z |
Cancer cell uptake behavior of Au nanoring and its localized surface plasmon resonance induced cell inactivation
|
Chu, C.-K.;Tu, Y.-C.;Chang, Y.-W.;Chu, C.-K.;Chen, S.-Y.;Chi, T.-T.;Kiang, Y.-W.;Yang, C.-C.; Chu, C.-K.; Tu, Y.-C.; Chang, Y.-W.; Chu, C.-K.; Chen, S.-Y.; Chi, T.-T.; Kiang, Y.-W.; Yang, C.-C.; YEAN-WOEI KIANG |
| 臺大學術典藏 |
2015 |
Cancer cell uptake behavior of Au nanoring and its localized surface plasmon resonance induced cell inactivation
|
Chu, C.-K.; Tu, Y.-C.; Chang, Y.-W.; Chu, C.-K.; Chen, S.-Y.; Chi, T.-T.; Kiang, Y.-W.; Yang, C.-C.; CHIH-CHUNG YANG; Chu, C.-K.;Tu, Y.-C.;Chang, Y.-W.;Chu, C.-K.;Chen, S.-Y.;Chi, T.-T.;Kiang, Y.-W.;Yang, C.-C. |
| 國家衛生研究院 |
2010-09 |
Cancer cells acquire mitotic drug resistance properties through beta i-tubulin mutations and alterations in the expression of beta-tubulin isotypes
|
Cheung, CHA;Wu, SY;Lee, TR;Chang, CY;Wu, JS;Hsieh, HP;Chang, JY |
| 臺大學術典藏 |
2020-06-11T06:32:24Z |
Cancer cells differentiation by multi-color ZnO and TiO2 nanowires
|
Li, W.-J.;Yang, S.-C.;Shen, Y.-C.;Huang, J.-J.;Yang, T.-L.; Li, W.-J.; Yang, S.-C.; Shen, Y.-C.; Huang, J.-J.; Yang, T.-L.; JIAN-JANG HUANG |
| 臺大學術典藏 |
2018-09-10T18:05:41Z |
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
|
Cheng, H.-W. And Chen, Y.-F. And Wong, J.-M. And Weng, C.-W. And Chen, H.-Y. And Yu, S.-L. And Chen, H.-W. And Yuan, A. And Chen, J.J.W.; SUNG-LIANG YU; ANG YUAN; HUEI-WEN CHEN |
| 臺大學術典藏 |
2020-06-17T03:01:31Z |
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
|
Chen J.J.W.; Yuan A.; Chen H.-W.; Cheng H.-W.;Chen Y.-F.;Wong J.-M.;Weng C.-W.;Chen H.-Y.;Sung-Liang Yu;Chen H.-W.;Yuan A.;Chen J.J.W.; Cheng H.-W.; Chen Y.-F.; Wong J.-M.; Weng C.-W.; Chen H.-Y.; SUNG-LIANG YU |
| 臺大學術典藏 |
2020-03-26T06:54:21Z |
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
|
Cheng H.-W.;Chen Y.-F.;Wong J.-M.;Weng C.-W.;Chen H.-Y.;Yu S.-L.;Chen H.-W.;Ang Yuan;Chen J.J.W.; Cheng H.-W.; Chen Y.-F.; Wong J.-M.; Weng C.-W.; Chen H.-Y.; Yu S.-L.; Chen H.-W.; ANG YUAN; Chen J.J.W. |
| 臺大學術典藏 |
2022-03-09T03:12:24Z |
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
|
Cheng H.-W.; Chen Y.-F.; Wong J.-M.; Weng C.-W.; Chen H.-Y.; Yu S.-L.; HUEI-WEN CHEN; Yuan A.; Chen J.J.W. |
| 國立臺灣大學 |
1999 |
Cancer Chemoprevention by Tea Polyphenols through Mitotic Signal Blockade , a Commentary
|
林仁混; 梁有志; 蕭水銀; LIN, JEN-KUN; LIANG, YU-CHIH; LIN-SHIAU, SHOEI-YN |
| 臺北醫學大學 |
1999 |
Cancer chemoprevention by tea polyphenols through mitotic signal blockade, a commentary.
|
梁有志; Lin; J.K.; Liang; Y.C. and Lin-Shiau; S.Y. |
| 臺北醫學大學 |
2000 |
Cancer Chemoprevention by Tea Polyphenols- a review.
|
梁有志; Lin; J.K. and Liang; Y.C. |
| 國立臺灣大學 |
2000 |
Cancer Chemoprevention of Cancer by Tea Polyphenols
|
林仁混; 梁有志; LIN, JEN-KUN; LIANG, YU-CHIH |
| 國立成功大學 |
2003-04-25 |
Cancer chemopreventive activity of acridone alkaloids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis
|
Itoigawa, Masataka; Ito, Chihiro; Wu, Tian-Shung; Enjo, Fumio; Tokuda, Harukuni; Nishino, Hoyoku; Furukawa, Hiroshi |
| 高雄醫學大學 |
2014 |
CANCER CHEMOTH PHARM
|
阮懷磊;楊志仁;尹莘玲;王東衡;黃吉志;黃明賢; Juan, Huai-Lei;Yang, Chih-Jen;Yin, Hsin-Ling;Wang, Tung-Heng;Hwang, Jhi-Jhu;Huang , Ming-Shyan |
| 國立成功大學 |
2021 |
Cancer DEIso: An integrative analysis platform for investigating differentially expressed gene-level and isoform-level human cancer markers
|
Yang;Tzu-Hsien;Chiang;Yu-Hsuan;Shiue;Sheng-Cian;Lin;Po-Heng;Yang;Ya-Chiao;Tu;Kai-Chi;Tseng;Yan-Yuan;Tseng;Joseph, T.;Wu;Wei-Sheng |
| 國立成功大學 |
2021-09-01 |
Cancer DEIso: An integrative analysis platform for investigating differentially expressed gene-level and isoform-level human cancer markers.
|
曾大千; TSENG, TA-CHIEN; Yang, T. H., Chiang, Y. H., Shiue, S. C., Lin, P. H., Yang, Y. C., Tu, K. C., Tseng, Y. Y., Tseng, J. T., & Wu, W. S. |
| 嘉南藥理大學 |
2009 |
Cancer Detection and Prevention
|
Elsevier SDOL |
| 國立臺北護理健康大學 |
2004 |
Cancer Diagnosis and Prognosis in Taiwan：Patience Preferences Versus experiences
|
邱秀渝; Tzuh, Tang Siew;Lee Shiu-Yu, C. |
| 國立臺灣大學 |
2010 |
Cancer Epidemiology and Control in North-East Asia - Past, Present and Future
|
賴美淑; LAI, MEI-SHU |
| 國立臺灣大學 |
2002 |
CANCER EPIDEMIOLOGY AND CONTROL IN TAIWAN: A BRIEF REVIEW
|
CHEN, CHIEN-JEN; 陳建仁 |
| 國立臺灣大學 |
1990 |
Cancer Epidemiology in Taiwan:Patterns in a Rapidly Industrializing Society
|
林瑞雄; Lin, Ruey-Shiung |
| 臺大學術典藏 |
2018-09-10T08:33:04Z |
Cancer epigenetics: Linking basic biology to clinical medicine
|
Tsai, H.-C. Baylin, S.B.; HSING-CHEN TSAI |
| 臺大學術典藏 |
2021-06-30T08:46:40Z |
Cancer epigenetics: Linking basic biology to clinical medicine
|
HSING-CHEN TSAI; Baylin S.B. |
| 臺大學術典藏 |
2021-06-30T08:46:39Z |
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
|
Easwaran H.; HSING-CHEN TSAI; Baylin S.B. |
| 亞洲大學 |
2009 |
Cancer Gene and Metabolic Pathway Analysis
|
Lee,Zhong-Hung |
| 臺大學術典藏 |
2019-11-20T08:09:58Z |
Cancer gene mutations in congenital pulmonary airway malformation patients
|
Jacob Shujui Hsu;Zhang, Ruizhong;Yeung, Fanny;Tang, Clara S.M.;Wong, John K.L.;So, Man-Ting;Xiao-Gang He;Sham, Pak;Tam, Paul K.;Li, Miaoxin;Wong, Kenneth K.Y.;Garcia-Barcelo, Maria-Merc?; Jacob Shujui Hsu; Zhang, Ruizhong; Yeung, Fanny; Tang, Clara S.M.; Wong, John K.L.; So, Man-Ting; XIAO-GANG HE; Sham, Pak; Tam, Paul K.; Li, Miaoxin; Wong, Kenneth K.Y.; Garcia-Barcelo, Maria-Mercè |
| 嘉南藥理大學 |
2009 |
Cancer Genetics and Cytogenetics
|
Elsevier SDOL |
| 元智大學 |
2013-07-22 |
Cancer Genome Assembly and Alignment
|
M Ho; KY Hung; YS Gen; Chaochang Chiu; TH Lu |
| 亞洲大學 |
2016 |
Cancer Genome Characteristics and Anticancer Drug Screening
|
Hsiao, Ya-Li |
| 嘉南藥理大學 |
2013-07 |
Cancer history, bandemia, and serum creatinine are independent mortality predictors in patients with infection-precipitated hyperglycemic crises
|
Huang, Chien-Cheng; Chou, Willy; Lin, Hung-Jung; Chen, Shih-Chung; Kuo, Shu-Chun; Chen, Wei-Lung; Chen, Jiann-Hwa; Wang, Hsien-Yi; Guo, How-Ran |
| 國立成功大學 |
2013-07-16 |
Cancer history, bandemia, and serum creatinine are independent mortality predictors in patients with infection-precipitated hyperglycemic crises
|
Huang, Chien-Cheng; Chou, Willy; Lin, Hung-Jung; Chen, Shih-Chung; Kuo, Shu-Chun; Chen, Wei-Lung; Chen, Jiann-Hwa; Wang, Hsien-Yi; Guo, How-Ran |
| 國立成功大學 |
2020-12 |
Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators
|
Debele;Ayane, Tilahun;Yeh;Cheng-Fa;Su;Wen-Pin |
| 臺大學術典藏 |
2021-02-02T02:47:57Z |
Cancer immunotherapy by targeting immune checkpoints: Mechanism of T cell dysfunction in cancer immunity and new therapeutic targets John T Kung
|
Tsai H.-F.; PING-NING HSU |
| 國立臺灣大學 |
2001 |
Cancer Immunotherapy Using a DNA Vaccine Encoding the Translocation Domain of a Bacterial Toxin Linked to a Tumor Antigen
|
鄭文芳; CHENG, WEN-FANG |
| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
|
Wu T.-C.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:25Z |
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
|
Hung C.-F.;Wen-Fang Cheng;Hsu K.-F.;Chai C.-Y.;He L.;Ling M.;Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 國立臺灣大學 |
2002 |
Cancer Immunotherapy Using Sindbis Virus Replicon Particles Encoding a Vp 22-Antigen Fusion
|
鄭文芳; CHENG, WEN-FANG |
| 臺大學術典藏 |
2018-09-10T04:06:43Z |
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
|
Cheng, W.-F. and Hung, C.-F. and Hsu, K.-F. and Chai, C.-Y. and He, L. and Polo, J.M. and Slater, L.A. and Ling, M. and Wu, T.-C.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:22:40Z |
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
|
Wu T.-C.;Ling M.;Slater L.A.;Polo J.M.;He L.;Chai C.-Y.;Hsu K.-F.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:21Z |
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
|
Wen-Fang Cheng;Hung C.-F.;Hsu K.-F.;Chai C.-Y.;He L.;Polo J.M.;Slater L.A.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. |
| 國立成功大學 |
2019 |
Cancer immunotherapy: Silencing intracellular negative immune regulators of dendritic cells
|
Liu, Y.-H.;Yeh, I.-J.;Lai, M.-D.;Liu, K.-T.;Kuo, P.-L.;Yen, M.-C. |
| 國立臺灣大學 |
2006 |
CANCER IN CHILDREN OF ELECTRONICS INDUSTRY EMPLOYEES
|
CHEN, PAU-CHUNG; WANG, JUNG-DER; 陳保中; 王德榮 |
| 國立臺灣大學 |
2005 |
CANCER INCIDENCE AMONG WORK.ERS POTENTIALLY EXPOSED TO CHLORINATED SOLVENTS IN AN ELECTRONICS FACTORY
|
SUNG, FUNG-CHANG; 宋鴻樟 |
